Development of new pharmaceutical compounds for the treatment of inflamed intestine, colon cancer and immune diseases
Oncostellae has raised €4.3M across 4 funding rounds from 9 investors, most recently a round in Jul 2023. Based in Santiago de Compostela, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-07-05 | Other | €500k | Bio & Tech Smart Capital FCRE,Noso Capital SGEIC,Santiago Domínguez | View deal → |
| 2022-11-23 | Crowdfunding | €2.0M | Capital Cell | View deal → |
| 2022-11-23 | Other | €1.3M | Fitalent,Inveready,Unirisco,XesGalicia | View deal → |
| 2022-07-06 | Debt | €500k | Fitalent,Inveready,Julio Castro,XesGalicia | View deal → |
